TY - JOUR AU - Inzucchi, S. E. AU - Bergenstal, R. M. AU - Buse, J. B. AU - Diamant, M. AU - Ferrannini, E. AU - Nauck, M. AU - Peters, A. L. AU - Tsapas, A. AU - Wender, R. AU - Matthews, D. R. PY - 2015 DA - 2015// TI - Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes JO - Diabetes Care VL - 38 UR - https://doi.org/10.2337/dc14-2441 DO - 10.2337/dc14-2441 ID - Inzucchi2015 ER - TY - JOUR AU - Lathief, S. AU - Inzucchi, S. E. PY - 2016 DA - 2016// TI - Approach to diabetes management in patients with CVD JO - Trends Cardiovasc Med VL - 26 UR - https://doi.org/10.1016/j.tcm.2015.05.005 DO - 10.1016/j.tcm.2015.05.005 ID - Lathief2016 ER - TY - JOUR AU - Seshasai, S. R. AU - Kaptoge, S. AU - Thompson, A. AU - Angelantonio, E. AU - Gao, P. AU - Sarwar, N. AU - Whincup, P. H. AU - Mukamal, K. J. AU - Gillum, R. F. AU - Holme, I. PY - 2011 DA - 2011// TI - Diabetes mellitus, fasting glucose, and risk of cause-specific death JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1008862 DO - 10.1056/NEJMoa1008862 ID - Seshasai2011 ER - TY - JOUR AU - Smith, R. J. AU - Goldfine, A. B. AU - Hiatt, W. R. PY - 2016 DA - 2016// TI - Evaluating the cardiovascular safety of new medications for type 2 diabetes: time to reassess? JO - Diabetes Care VL - 39 UR - https://doi.org/10.2337/dc15-2237 DO - 10.2337/dc15-2237 ID - Smith2016 ER - TY - JOUR AU - Avogaro, A. AU - Fadini, G. P. AU - Sesti, G. AU - Bonora, E. AU - Prato, S. PY - 2016 DA - 2016// TI - Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0431-4 DO - 10.1186/s12933-016-0431-4 ID - Avogaro2016 ER - TY - JOUR AU - Abdul-Ghani, M. A. AU - Norton, L. AU - Defronzo, R. A. PY - 2011 DA - 2011// TI - Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes JO - Endocr Rev VL - 32 UR - https://doi.org/10.1210/er.2010-0029 DO - 10.1210/er.2010-0029 ID - Abdul-Ghani2011 ER - TY - JOUR AU - Plosker, G. L. PY - 2014 DA - 2014// TI - Dapagliflozin: a review of its use in patients with type 2 diabetes JO - Drugs VL - 74 UR - https://doi.org/10.1007/s40265-014-0324-3 DO - 10.1007/s40265-014-0324-3 ID - Plosker2014 ER - TY - JOUR AU - Zinman, B. AU - Wanner, C. AU - Lachin, J. M. AU - Fitchett, D. AU - Bluhmki, E. AU - Hantel, S. AU - Mattheus, M. AU - Devins, T. AU - Johansen, O. E. AU - Woerle, H. J. PY - 2015 DA - 2015// TI - Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504720 DO - 10.1056/NEJMoa1504720 ID - Zinman2015 ER - TY - JOUR AU - Ingelfinger, J. R. AU - Rosen, C. J. PY - 2015 DA - 2015// TI - Cardiovascular risk and sodium-glucose cotransporter 2 inhibition in type 2 diabetes JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMe1512602 DO - 10.1056/NEJMe1512602 ID - Ingelfinger2015 ER - TY - JOUR AU - Luconi, M. AU - Raimondi, L. AU - Franco, A. AU - Mannucci, E. PY - 2016 DA - 2016// TI - Which is the main molecular target responsible for the cardiovascular benefits in the EMPA-REG OUTCOME trial? A journey through the kidney, the heart and other interesting places JO - Nutr Metab Cardiovasc Dis VL - 26 UR - https://doi.org/10.1016/j.numecd.2016.09.001 DO - 10.1016/j.numecd.2016.09.001 ID - Luconi2016 ER - TY - JOUR AU - Heerspink, H. J. AU - Perkins, B. A. AU - Fitchett, D. H. AU - Husain, M. AU - Cherney, D. Z. PY - 2016 DA - 2016// TI - Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications JO - Circulation VL - 134 UR - https://doi.org/10.1161/CIRCULATIONAHA.116.021887 DO - 10.1161/CIRCULATIONAHA.116.021887 ID - Heerspink2016 ER - TY - JOUR AU - Ferrannini, E. AU - Mark, M. AU - Mayoux, E. PY - 2016 DA - 2016// TI - CV protection in the EMPA-REG OUTCOME trial: a “thrifty substrate” hypothesis JO - Diabetes Care VL - 39 UR - https://doi.org/10.2337/dc16-0330 DO - 10.2337/dc16-0330 ID - Ferrannini2016 ER - TY - JOUR AU - Zaccardi, F. AU - Webb, D. R. AU - Htike, Z. Z. AU - Youssef, D. AU - Khunti, K. AU - Davies, M. J. PY - 2016 DA - 2016// TI - Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis JO - Diabetes Obes Metab VL - 18 UR - https://doi.org/10.1111/dom.12670 DO - 10.1111/dom.12670 ID - Zaccardi2016 ER - TY - JOUR AU - Bode, B. AU - Stenlof, K. AU - Harris, S. AU - Sullivan, D. AU - Fung, A. AU - Usiskin, K. AU - Meininger, G. PY - 2015 DA - 2015// TI - Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetes JO - Diabetes Obes Metab VL - 17 UR - https://doi.org/10.1111/dom.12428 DO - 10.1111/dom.12428 ID - Bode2015 ER - TY - JOUR AU - Inagaki, N. AU - Harashima, S. AU - Maruyama, N. AU - Kawaguchi, Y. AU - Goda, M. AU - Iijima, H. PY - 2016 DA - 2016// TI - Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0407-4 DO - 10.1186/s12933-016-0407-4 ID - Inagaki2016 ER - TY - JOUR AU - Matthaei, S. AU - Bowering, K. AU - Rohwedder, K. AU - Sugg, J. AU - Parikh, S. AU - Johnsson, E. PY - 2015 DA - 2015// TI - Durability and tolerability of dapagliflozin over 52 weeks as add-on to metformin and sulphonylurea in type 2 diabetes JO - Diabetes Obes Metab VL - 17 UR - https://doi.org/10.1111/dom.12543 DO - 10.1111/dom.12543 ID - Matthaei2015 ER - TY - JOUR AU - Katsuyama, H. AU - Hamasaki, H. AU - Adachi, H. AU - Moriyama, S. AU - Kawaguchi, A. AU - Sako, A. AU - Mishima, S. AU - Yanai, H. PY - 2016 DA - 2016// TI - Effects of sodium-glucose cotransporter 2 inhibitors on metabolic parameters in patients with type 2 diabetes: a chart-based analysis JO - J Clin Med Res VL - 8 UR - https://doi.org/10.14740/jocmr2467w DO - 10.14740/jocmr2467w ID - Katsuyama2016 ER - TY - JOUR AU - Taskinen, M. R. PY - 2003 DA - 2003// TI - Diabetic dyslipidaemia: from basic research to clinical practice JO - Diabetologia VL - 46 UR - https://doi.org/10.1007/s00125-003-1111-y DO - 10.1007/s00125-003-1111-y ID - Taskinen2003 ER - TY - JOUR AU - Rosenblit, P. D. PY - 2016 DA - 2016// TI - Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile? JO - Cardiovasc Diabetol VL - 15 UR - https://doi.org/10.1186/s12933-016-0412-7 DO - 10.1186/s12933-016-0412-7 ID - Rosenblit2016 ER - TY - JOUR AU - Nofer, J. R. AU - Kehrel, B. AU - Fobker, M. AU - Levkau, B. AU - Assmann, G. AU - Eckardstein, A. PY - 2002 DA - 2002// TI - HDL and arteriosclerosis: beyond reverse cholesterol transport JO - Atherosclerosis VL - 161 UR - https://doi.org/10.1016/S0021-9150(01)00651-7 DO - 10.1016/S0021-9150(01)00651-7 ID - Nofer2002 ER - TY - JOUR AU - Khera, A. V. AU - Cuchel, M. AU - Llera-Moya, M. AU - Rodrigues, A. AU - Burke, M. F. AU - Jafri, K. AU - French, B. C. AU - Phillips, J. A. AU - Mucksavage, M. L. AU - Wilensky, R. L. PY - 2011 DA - 2011// TI - Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1001689 DO - 10.1056/NEJMoa1001689 ID - Khera2011 ER - TY - JOUR AU - Levey, A. S. AU - Stevens, L. A. AU - Schmid, C. H. AU - Zhang, Y. L. AU - Castro, A. F. AU - Feldman, H. I. AU - Kusek, J. W. AU - Eggers, P. AU - Lente, F. AU - Greene, T. PY - 2009 DA - 2009// TI - A new equation to estimate glomerular filtration rate JO - Ann Intern Med VL - 150 UR - https://doi.org/10.7326/0003-4819-150-9-200905050-00006 DO - 10.7326/0003-4819-150-9-200905050-00006 ID - Levey2009 ER - TY - JOUR PY - 2002 DA - 2002// TI - K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification JO - Am J Kidney Dis VL - 39 ID - ref23 ER - TY - JOUR PY - 1999 DA - 1999// TI - Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10 JO - Ophthalmology VL - 98 ID - ref24 ER - TY - JOUR AU - Sankaranarayanan, S. AU - Kellner-Weibel, G. AU - Llera-Moya, M. AU - Phillips, M. C. AU - Asztalos, B. F. AU - Bittman, R. AU - Rothblat, G. H. PY - 2011 DA - 2011// TI - A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol JO - J Lipid Res VL - 52 UR - https://doi.org/10.1194/jlr.D018051 DO - 10.1194/jlr.D018051 ID - Sankaranarayanan2011 ER - TY - JOUR AU - Huen, K. AU - Richter, R. AU - Furlong, C. AU - Eskenazi, B. AU - Holland, N. PY - 2009 DA - 2009// TI - Validation of PON1 enzyme activity assays for longitudinal studies JO - Clin Chim Acta VL - 402 UR - https://doi.org/10.1016/j.cca.2008.12.019 DO - 10.1016/j.cca.2008.12.019 ID - Huen2009 ER - TY - JOUR AU - Fadini, G. P. AU - Rigato, M. AU - Boscari, F. AU - Cappellari, R. AU - Menegazzo, L. AU - Pilutti, C. AU - Iori, E. AU - Marescotti, M. AU - Plebani, M. AU - Albiero, M. PY - 2015 DA - 2015// TI - Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients JO - Vascul Pharmacol VL - 67–69 UR - https://doi.org/10.1016/j.vph.2014.11.005 DO - 10.1016/j.vph.2014.11.005 ID - Fadini2015 ER - TY - JOUR AU - Fadini, G. P. AU - Iori, E. AU - Marescotti, M. C. AU - Kreutzenberg, S. V. AU - Avogaro, A. PY - 2014 DA - 2014// TI - Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients JO - Atherosclerosis VL - 235 UR - https://doi.org/10.1016/j.atherosclerosis.2014.05.942 DO - 10.1016/j.atherosclerosis.2014.05.942 ID - Fadini2014 ER - TY - JOUR AU - Eckardstein, A. AU - Nofer, J. R. AU - Assmann, G. PY - 2001 DA - 2001// TI - High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport JO - Arterioscler Thromb Vasc Biol VL - 21 UR - https://doi.org/10.1161/01.ATV.21.1.13 DO - 10.1161/01.ATV.21.1.13 ID - Eckardstein2001 ER - TY - JOUR AU - Ronsein, G. E. AU - Vaisar, T. PY - 2017 DA - 2017// TI - Inflammation, remodeling, and other factors affecting HDL cholesterol efflux JO - Curr Opin Lipidol VL - 28 ID - Ronsein2017 ER - TY - JOUR AU - Plosker, G. L. PY - 2012 DA - 2012// TI - Dapagliflozin: a review of its use in type 2 diabetes mellitus JO - Drugs VL - 72 UR - https://doi.org/10.2165/11209910-000000000-00000 DO - 10.2165/11209910-000000000-00000 ID - Plosker2012 ER - TY - JOUR AU - Ponzani, P. AU - Scardapane, M. AU - Nicolucci, A. AU - Rossi, M. C. PY - 2016 DA - 2016// TI - Effectiveness and safety of liraglutide after 3 years of treatment JO - Minerva Endocrinol VL - 41 ID - Ponzani2016 ER - TY - JOUR AU - Simo, R. AU - Guerci, B. AU - Schernthaner, G. AU - Gallwitz, B. AU - Rosas-Guzman, J. AU - Dotta, F. AU - Festa, A. AU - Zhou, M. AU - Kiljanski, J. PY - 2015 DA - 2015// TI - Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study JO - Cardiovasc Diabetol VL - 14 UR - https://doi.org/10.1186/s12933-015-0279-z DO - 10.1186/s12933-015-0279-z ID - Simo2015 ER - TY - JOUR AU - Blonde, L. AU - Pencek, R. AU - MacConell, L. PY - 2015 DA - 2015// TI - Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes JO - Cardiovasc Diabetol VL - 14 UR - https://doi.org/10.1186/s12933-014-0171-2 DO - 10.1186/s12933-014-0171-2 ID - Blonde2015 ER - TY - JOUR AU - Zhang, C. AU - Gao, F. AU - Luo, H. AU - Zhang, C. T. AU - Zhang, R. PY - 2015 DA - 2015// TI - Differential response in levels of high-density lipoprotein cholesterol to 1-year metformin treatment in prediabetic patients by race/ethnicity JO - Cardiovasc Diabetol VL - 14 UR - https://doi.org/10.1186/s12933-015-0240-1 DO - 10.1186/s12933-015-0240-1 ID - Zhang2015 ER - TY - JOUR AU - Hirose, S. AU - Nakajima, S. AU - Iwahashi, Y. AU - Seo, A. AU - Takahashi, T. AU - Tamori, Y. PY - 2016 DA - 2016// TI - Impact of the 8-week administration of tofogliflozin for glycemic control and body composition in Japanese patients with type 2 diabetes mellitus JO - Intern Med VL - 55 UR - https://doi.org/10.2169/internalmedicine.55.6367 DO - 10.2169/internalmedicine.55.6367 ID - Hirose2016 ER - TY - JOUR AU - Piccoli, A. PY - 2010 DA - 2010// TI - Bioelectric impedance measurement for fluid status assessment JO - Contrib Nephrol VL - 164 UR - https://doi.org/10.1159/000313727 DO - 10.1159/000313727 ID - Piccoli2010 ER - TY - JOUR AU - Minocci, A. AU - Savia, G. AU - Lucantoni, R. AU - Berselli, M. E. AU - Tagliaferri, M. AU - Calo, G. AU - Petroni, M. L. AU - Medici, C. AU - Viberti, G. C. AU - Liuzzi, A. PY - 2000 DA - 2000// TI - Leptin plasma concentrations are dependent on body fat distribution in obese patients JO - Int J Obes Relat Metab Disord VL - 24 UR - https://doi.org/10.1038/sj.ijo.0801385 DO - 10.1038/sj.ijo.0801385 ID - Minocci2000 ER - TY - JOUR AU - Bolinder, J. AU - Ljunggren, O. AU - Johansson, L. AU - Wilding, J. AU - Langkilde, A. M. AU - Sjostrom, C. D. AU - Sugg, J. AU - Parikh, S. PY - 2014 DA - 2014// TI - Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin JO - Diabetes Obes Metab VL - 16 UR - https://doi.org/10.1111/dom.12189 DO - 10.1111/dom.12189 ID - Bolinder2014 ER - TY - JOUR AU - Bolinder, J. AU - Ljunggren, O. AU - Kullberg, J. AU - Johansson, L. AU - Wilding, J. AU - Langkilde, A. M. AU - Sugg, J. AU - Parikh, S. PY - 2012 DA - 2012// TI - Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin JO - J Clin Endocrinol Metab VL - 97 UR - https://doi.org/10.1210/jc.2011-2260 DO - 10.1210/jc.2011-2260 ID - Bolinder2012 ER - TY - JOUR AU - Lukaski, H. C. AU - Bolonchuk, W. W. AU - Hall, C. B. AU - Siders, W. A. PY - 1986 DA - 1986// TI - Validation of tetrapolar bioelectrical impedance method to assess human body composition JO - J Appl Physiol VL - 60 ID - Lukaski1986 ER -